We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Baxter International Inc | NYSE:BAX | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.09 | 0.24% | 37.00 | 37.43 | 36.50 | 37.23 | 6,246,790 | 01:00:00 |
From May 2019 to May 2024
Baxter International Inc. (NYSE: BAX) will present at the 6th Annual Leerink Partners Global Healthcare Conference on Wednesday, February 15, 2017, in New York City. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:30 p.m. Eastern Standard Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through April 15, 2017.
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170119005791/en/
Baxter International Inc.Media ContactBill Rader(224) 948-5353media@baxter.comorInvestor ContactClare Trachtman(224) 948-3085
1 Year Baxter Chart |
1 Month Baxter Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
